📊 Score Breakdown
Offering Ability
40
Cash Runway
95
Float Risk
40
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
51%
💰 Capital Raise
55%
• Critical: only 2.7 months cash remaining
📉 Score Deterioration
50%
• Score rose 41 points recently (worsening)
• Score in HIGH risk zone (65/100)
🔄 Reverse Split
45%
• 50-day avg $1.90 approaching $1 threshold
• Only 3 months cash — financial pressure
💹 Market Data
Market Cap$9.02M
Shares Outstanding1.58M
FloatN/A
Cash$3.17M
Debt$2.54M
Short InterestN/A
🏛 Institutional Holdings
2 institutional holders · 18 shares
#1
UBS Group AG
15 shares
#2
Blackrock Inc.
3 shares
📉 Short Interest
Short Interest70.4K
Days to Cover1.0
% of Float1.9%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for JDZG
📊 JDZG FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 JDZG Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.